Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...

A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...

"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...

Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

The new team carries out testing in emergency departments in Wolverhampton and Walsall.

Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...

During a test drive, the mobile lab van uncovered a drug-resistant HIV strain that sprung up after the ongoing war with Russia started.

A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...